Internal dosimetry for systemic radiation therapy.
The key to effective use of the medical internal radiation dose (MIRD) schema in radioimmunotherapy (RIT) is to understand how it works and what the essential data input requirements are. The fundamental data are acquired from medical imaging. Image interpretation involves (1) collecting data to determine the source-organ activities, (2) plotting the source-organ time-activity curves, (3) integrating the time-activity curves for an estimate of the residence time, and (4) applying the residence time values (for each important source organ) within the MIRD schema to calculate the tissue absorbed dose to target organs and tumors of interest. This article reviews methods for calculating internal dose. It also describes methods for selecting sampling times, integrating the area under the data curves, and customizing a dose assessment for a patient who does not resemble the MIRD phantom. A sample dose assessment is given, together with common mistakes to avoid. Three approaches to red marrow dosimetry are described. With the increased use of RIT agents for cancer treatment, a solid understanding of internal dose methods is essential for treatment planning and follow-up evaluations.
Fisher
D R
DR
Hanford Radioisotopes and Medical Sciences Program, Pacific Northwest National Laboratory, Richland, WA 99352, USA.
D019540:Area Under Curve; D001853:Bone Marrow / Q000528:radiation effects; D006207:Half-Life; D006801:Humans; D008433:Mathematics; D009369:Neoplasms / Q000532:radiotherapy*; D010347:Patient Care Planning; D016499:Radioimmunotherapy; D011868:Radioisotopes / Q000493:pharmacokinetics*; D011879:Radiotherapy Dosage / Q000592:standards*; D011880:Radiotherapy Planning, Computer-Assisted
D011868:Radioisotopes